Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) PT at $8.63

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $8.58.

LFST has been the subject of several recent research reports. KeyCorp started coverage on LifeStance Health Group in a research report on Tuesday. They set an "overweight" rating and a $9.00 price objective for the company. William Blair reaffirmed an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Canaccord Genuity Group started coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They issued a "buy" rating and a $8.00 price objective on the stock. Finally, The Goldman Sachs Group upgraded shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $10.00 target price for the company in a report on Monday, December 16th.

Insider Buying and Selling

In related news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 6.60% of the stock is owned by corporate insiders.

Remove Ads

Institutional Trading of LifeStance Health Group

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jennison Associates LLC lifted its position in LifeStance Health Group by 278.4% during the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock worth $59,597,000 after acquiring an additional 5,949,438 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in LifeStance Health Group by 87.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after acquiring an additional 1,643,390 shares during the period. Vanguard Group Inc. increased its position in shares of LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock worth $78,781,000 after purchasing an additional 784,818 shares during the period. Geode Capital Management LLC increased its holdings in LifeStance Health Group by 26.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock valued at $24,170,000 after buying an additional 729,794 shares during the period. Finally, Wellington Management Group LLP raised its position in LifeStance Health Group by 15.2% during the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company's stock valued at $33,813,000 after purchasing an additional 638,385 shares in the last quarter. Institutional investors own 85.50% of the company's stock.

LifeStance Health Group Stock Up 2.3 %

NASDAQ LFST traded up $0.15 on Thursday, reaching $6.66. The company had a trading volume of 987,821 shares, compared to its average volume of 1,575,568. The company's fifty day moving average is $7.44 and its 200-day moving average is $7.34. The firm has a market capitalization of $2.56 billion, a price-to-earnings ratio of -25.58 and a beta of 1.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32. LifeStance Health Group has a 1-year low of $4.64 and a 1-year high of $8.61.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.